The establishment of a grant program to fund the United States Food and Drug Administration's drug development trials with ibogaine for the purpose of securing the administration's approval as a medication for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy

Relating to the establishment of a grant program to fund the United States Food and Drug Administration's drug development trials with ibogaine for the purpose of securing the administration's approval as a medication for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy.

Source: OpenStates · fetched May 12, 2025

• Mental health service userdirectModerate impactHigh certainty

  Potential access to a new medication for opioid use disorder, co-occurring substance use disorder, and other neurological or mental health conditions.

  “Relating to the establishment of a grant program to fund the United States Food and Drug Administration's drug development trials with ibogaine for the purpose of securing the administration's approval as a medication for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy.”· Relating to

• TX HB149Regulation of the use of artificial intelligence systems in this state; providing civil penalties
• TX HB305The time period for conducting pretrial hearings after a criminal defendant has been restored to competency
• TX HB500Making supplemental appropriations and reductions in appropriations and giving direction and adjustment authority regarding appropriations
• TX HB1052Health benefit plan coverage of telemedicine, teledentistry, and telehealth appointments with an originating site or distant site located outside this state
• TX SB3The regulation of products derived from hemp, including consumable hemp products and the hemp-derived cannabinoids contained in those products; requiring occupational licenses and permits; imposing fees; creating criminal offenses; authorizing an administrative penalty

• WV HB4626Relating to the establishment of a grant program to fund the United States Food and Drug Administration’s drug development trials with ibogaine